442
Participants
Start Date
August 2, 2021
Primary Completion Date
December 10, 2021
Study Completion Date
December 10, 2021
Emodepside
Treatment with ascending doses of emodepside (from 5 mg to 30 mg) or albendazole (400 mg) or placebo.
Public Health Laboratory - Ivo de Carneri, Chake Chake
Public Health Laboratory Ivo de Carneri
OTHER
Jennifer Keiser
OTHER